We are live on
!
Find out more
JAM
JW Asset Management Portfolio holdings
AUM
$244M
1-Year Est. Return
71.51%
This Fund
S&P 500
This Quarter
Est. Return
+42.62%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$231M
AUM Growth
+$98M
(+74%)
Cap. Flow
+$63.2M
Cap. Flow
% of AUM
27.33%
Top 10 Holdings %
Top 10 Hldgs %
69.94%
Holding
63
New
6
Increased
32
Reduced
6
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.7M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$18M |
| 3 |
BWLD
Buffalo Wild Wings, Inc.
BWLD
|
+$5.72M |
| 4 |
Blackstone
BX
|
+$4.96M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$4.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$8.13M |
| 2 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
+$4.19M |
| 3 |
Amazon
AMZN
|
+$731K |
| 4 |
Capri Holdings
CPRI
|
+$714K |
| 5 |
AGN
Allergan Inc
AGN
|
+$432K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 70.28% |
| 2 | Technology | 9.76% |
| 3 | Consumer Discretionary | 6.88% |
| 4 | Financials | 6.74% |
| 5 | Communication Services | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Rockwell Medical
RMTI
$28.4M
| – | – |
-38
| Closed | -$43K |
|
52
Sarepta Therapeutics
SRPT
$1.57B
| – | – |
-6,000
| Closed | -$87K |
|
53
Vivani Medical
VANI
$110M
| – | – |
-354
| Closed | -$87K |
|
54
Energous
WATT
$77.6M
| – | – |
-17
| Closed | -$110K |
|
|
ICPT
55
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-522
| Closed | -$81K |
|
|
PGNX
56
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| – | – |
-20,540
| Closed | -$156K |
|
|
IDXG
57
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| – | – |
-282
| Closed | -$51K |
|
|
SNMX
58
DELISTED
Senomyx, Inc.
SNMX
| – | – |
-5,108
| Closed | -$31K |
|
|
BTX.WS
59
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
| – | – |
-1,529
| Closed | -$2K |
|
|
ARIA
60
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| – | – |
-21,612
| Closed | -$148K |
|
|
POZN
61
DELISTED
POZEN INC
POZN
| – | – |
-14,653
| Closed | -$117K |
|
|
AST
62
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| – | – |
-1,250
| Closed | -$4K |
|
|
AGN
63
DELISTED
Allergan Inc
AGN
| – | – |
-2,032
| Closed | -$432K |
|
Similar funds
SC
HCM
SC
HBS
GIM
IFO
VG
BNMT
JW Asset Management's Q1 2015 Portfolio in Review
As of Q1 2015, JW Asset Management held 63 positions worth $231M, up 74% from $133M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
JW Asset Management deployed $63.2M of net new capital in Q1 2015, opening 6 new positions and adding to 32 existing holdings. Its largest new stake was Apple: 720,000 shares worth $22.4M.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 74% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $8.13M trimmed.
- JW Asset Management's largest Q1 2015 buy was Apple: 720,000 shares worth $22.4M.
- JW Asset Management added most to Eagle Pharmaceuticals, Inc. in Q1 2015, an estimated $18M increase.
- JW Asset Management's biggest Q1 2015 reduction was Tesla, cutting an estimated $8.13M.
- JW Asset Management fully exited Capri Holdings in Q1 2015, selling an estimated $714K.
- JW Asset Management's ten largest holdings make up 70% of its $231M portfolio in Q1 2015.
- JW Asset Management opened 6 new positions and closed 16 in Q1 2015.
- JW Asset Management's portfolio value rose 74% quarter-over-quarter to $231M.
Based on JW Asset Management's 13F filing for Q1 2015, filed 15 May 2015.